Market Tracker

04/17 2:37pm ET

SPDR S&P Pharmaceuticals ETF (XPH)

Data as of 2:22pm ET
 -0.156 / -0.17%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month-9.43% 3 years+23.26%
3 months-5.05% 5 years+28.76%
1 year+43.10% Since inception+15.75%
Data through 04/16/2014

Quote Details

Previous close$90.37
Open day’s range89.64 – 91.26
Net asset value (NAV)88.28 (04/15/2014)
Daily volume41,252
Average volume (3 months)147,722
Data as of 2:22pm ET, 04/17/2014

Peer Comparisonvs. Health ETFs

Performance 5-yr return+28.76%+25.56%
Expense Gross exp ratio0.35%0.43%
Risk 5 year sharpe ratio1.841.59
Net assets$871.0M$1.3B
Average market cap$8.0B$31.7B
Average P/E27.526.8
Dividend / Share--0.20%


RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care ETF
IXJ iShares Global Healthcare ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson3.69%
HZNP Horizon Pharma Inc3.61%
PFE Pfizer Inc3.59%
HSP Hospira, Inc.3.58%
QCOR Questcor Pharmaceuticals, Inc.3.57%
MRK Merck & Co Inc3.55%
VVUS Vivus3.50%
ABBV AbbVie Inc3.50%
LLY Eli Lilly and Company3.48%
ZTS Zoetis Inc3.43%